Nkarta receives fda clearance of ind application for nkx019 in lupus nephritis

New pipeline program builds on academic studies of durable, drug-free remissions in patients with autoimmune disease after cd19-targeted cell therapy
NKTX Ratings Summary
NKTX Quant Ranking